Please set your featured image
UK and Austrian mass spec agreement
Oxford Medical Diagnostics, a UK developer of breath based, medical diagnostic technology for the diagnosis and monitoring of metabolic and infectious diseases; and V&F Analyse- und Messtechnik, an Austrian provider of analytical instruments, announced a strategic alliance focusing on the area of mass spectrometry.
Under the terms of the new agreement, Oxford Medical Diagnostics will offer and support V&F’s high-performance mass spectrometry analysers in the UK and Ireland and establish a contract batch sample analysis service in its Oxford laboratories.
‘This is a great alliance for OMD, linking us to one of the most talented molecular analysis companies in the world. It brings analytical know-how, and the opportunity to earn revenues,’ said Oxford Medical Diagnostics CEO, Tony Marchington.
Target markets for the technology and analytical services include pharmaceutical, biotechnology, aerospace, fine chemicals, oil and gas, environmental and food and beverage analysis. OMD currently uses V&F’s technology to compare clinical results from diabetic patients with OMD’s proprietary laser-based breath analysis solutions.
In addition to this collaboration, the two companies report that they are looking into other opportunities for joint research. These include bacterial headspace analysis, as well as sports performance monitoring and healthy weight loss management.